Please join historian John Lesch, on April 27 at noon, as he briefly surveys AZT’s research origins, its role in expanding patient access to experimental drugs, and its trajectory as monotherapy. He will conclude by suggesting ways in which the AZT story highlights more general features of drug development in the early AIDS epidemic.
John Lesch is a historian of science and medicine, with a special interest in pharmaceuticals and the connections between academic, government, and industrial research. His publications include The First Miracle Drugs: How the Sulfa Drugs Transformed Medicine. He is professor emeritus of history, University of California, Berkeley.